Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s share price dropped 3.8% during mid-day trading on Wednesday . The stock traded as low as C$0.25 and last traded at C$0.26. 384,329 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Price Performance
The firm has a market cap of C$52.28 million and a P/E ratio of -0.37. The stock’s 50-day moving average is C$0.26 and its 200-day moving average is C$0.26. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.
Featured Articles
- Five stocks we like better than Emerald Health Therapeutics
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
